Mesenchymal Stem Cells Market - Top Companies and Manufacturers

  • Report ID: 3933
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Companies Dominating the Mesenchymal Stem Cells Landscape

    • Bio-Techne Corporation
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Merck KGaA
    • Genlantis, Inc.
    • Celprogen Corporation
    • PromoCell GmbH
    • Cyagen US Inc.
    • Plus Therapeutics, Inc.
    • Human Longevity, Inc.
    • Thermo Fisher Scientific Inc.
    • Pluristem Therapeutics Inc.

Browse Key Market Insights with Data Illustration:

In the News

  • Pluristem Therapeutics Inc. the leading biotechnology company in regenerative medicine, announced the commencement of its multinational Phase III multicenter research on muscle regeneration. The study has been conducted to support muscle regeneration associated with notable trauma such as hip fractures. The company is further noticed to develop placenta-based cell therapy products.

  • PromoCell GmbH to lead research on immunotherapies through all human primary cells and blood & stem cells, including MHC class I genes HLA-A, -B, and -C.


Author Credits:  Radhika Pawar


  • Report ID: 3933
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of mesenchymal stem cells is estimated at USD 4.38 billion.

The mesenchymal stem cells market size was over USD 3.93 billion in 2024 and is anticipated to cross USD 22.59 billion by 2037, witnessing more than 14.4% CAGR during the forecast period i.e., between 2025-2037. Rising demand for stem cell treatment in type 1 diabetes and the growing prevalence of genetic diseases and disorders will drive the market growth.

North America industry is set to account for largest revenue share of 43% by 2037, attributed to increasing adoption of advanced healthcare technologies in the region.

The major players in the market include Bio-Techne Corporation, Merck KGaA, Genlantis, Inc., Celprogen Corporation, PromoCell GmbH, Cyagen US Inc., Plus Therapeutics, Inc., Human Longevity, Inc., Thermo Fisher Scientific Inc., Pluristem Therapeutics Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample